These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25403919)

  • 1. n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.
    Hedengran A; Szecsi PB; Dyerberg J; Harris WS; Stender S
    Lipids; 2015 Feb; 50(2):165-75. PubMed ID: 25403919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors.
    Dawczynski C; Massey KA; Ness C; Kiehntopf M; Stepanow S; Platzer M; Grün M; Nicolaou A; Jahreis G
    Clin Nutr; 2013 Oct; 32(5):686-96. PubMed ID: 23332800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation.
    Schuchardt JP; Neubronner J; Block RC; von Schacky C; Hahn A
    Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):129-34. PubMed ID: 25108576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
    Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH
    J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
    Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N
    Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
    Kobayashi K; Hamazaki K; Fujioka S; Terao K; Yamamoto J; Kobayashi S
    Asia Pac J Clin Nutr; 2007; 16(3):429-34. PubMed ID: 17704023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial.
    Bays HE; Hallén J; Vige R; Fraser D; Zhou R; Hustvedt SO; Orloff DG; Kastelein JJ
    J Clin Lipidol; 2016; 10(1):181-91.e1-2. PubMed ID: 26892135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations.
    Sirtori CR; Crepaldi G; Manzato E; Mancini M; Rivellese A; Paoletti R; Pazzucconi F; Pamparana F; Stragliotto E
    Atherosclerosis; 1998 Apr; 137(2):419-27. PubMed ID: 9622285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia.
    Dai Perrard XY; Lian Z; Bobotas G; Dicklin MR; Maki KC; Wu H
    J Clin Lipidol; 2017; 11(6):1361-1371. PubMed ID: 28942094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
    Dunbar RL; Nicholls SJ; Maki KC; Roth EM; Orloff DG; Curcio D; Johnson J; Kling D; Davidson MH
    Lipids Health Dis; 2015 Sep; 14():98. PubMed ID: 26328624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans.
    Surette ME; Edens M; Chilton FH; Tramposch KM
    J Nutr; 2004 Jun; 134(6):1406-11. PubMed ID: 15173404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
    Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
    Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
    Hartweg J; Farmer AJ; Perera R; Holman RR; Neil HA
    Diabetologia; 2007 Aug; 50(8):1593-602. PubMed ID: 17541540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial.
    Schuchardt JP; Neubronner J; Kressel G; Merkel M; von Schacky C; Hahn A
    Prostaglandins Leukot Essent Fatty Acids; 2011 Dec; 85(6):381-6. PubMed ID: 21862301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of Omacor in severe hypertriglyceridemia.
    Harris WS; Ginsberg HN; Arunakul N; Shachter NS; Windsor SL; Adams M; Berglund L; Osmundsen K
    J Cardiovasc Risk; 1997; 4(5-6):385-91. PubMed ID: 9865671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial.
    Qi L; Zhang Q; Zheng Z; Pei Z; Mao H; Jiang T; Kazei D; Kahler E; Huo Y
    Vasc Health Risk Manag; 2021; 17():571-580. PubMed ID: 34552329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
    Stroes ESG; Susekov AV; de Bruin TWA; Kvarnström M; Yang H; Davidson MH
    J Clin Lipidol; 2018; 12(2):321-330. PubMed ID: 29289538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism.
    Roche HM; Gibney MJ
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):232S-7S. PubMed ID: 10617977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia.
    Pirillo A; Catapano AL
    Int J Cardiol; 2013 Dec; 170(2 Suppl 1):S16-20. PubMed ID: 23856442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.